IN2015DN00138A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN00138A IN2015DN00138A IN138DEN2015A IN2015DN00138A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A IN 138DEN2015 A IN138DEN2015 A IN 138DEN2015A IN 2015DN00138 A IN2015DN00138 A IN 2015DN00138A
- Authority
- IN
- India
- Prior art keywords
- library
- human germline
- antibody chains
- germline antibody
- human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/461—Igs containing Ig-regions, -domains or -residues form different species
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/005—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies constructed by phage libraries
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/22—Immunoglobulins specific features characterized by taxonomic origin from camelids, e.g. camel, llama or dromedary
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261695819P | 2012-08-31 | 2012-08-31 | |
| PCT/EP2013/068110 WO2014033304A2 (en) | 2012-08-31 | 2013-09-02 | Highly diverse combinatorial antibody libraries |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN00138A true IN2015DN00138A (no) | 2015-06-12 |
Family
ID=49117845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN138DEN2015 IN2015DN00138A (no) | 2012-08-31 | 2013-09-02 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10040870B2 (no) |
| EP (1) | EP2890709A2 (no) |
| JP (1) | JP6283030B2 (no) |
| CN (1) | CN104583236A (no) |
| AU (1) | AU2013310839B2 (no) |
| CA (1) | CA2879834A1 (no) |
| IL (1) | IL236524B (no) |
| IN (1) | IN2015DN00138A (no) |
| WO (1) | WO2014033304A2 (no) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2017014908A (es) | 2015-05-21 | 2018-08-15 | Harpoon Therapeutics Inc | Proteinas de union triespecificas y metodos de uso. |
| SG11201810331YA (en) | 2016-05-20 | 2018-12-28 | Harpoon Therapeutics Inc | Single chain variable fragment cd3 binding proteins |
| US11623958B2 (en) | 2016-05-20 | 2023-04-11 | Harpoon Therapeutics, Inc. | Single chain variable fragment CD3 binding proteins |
| KR102530742B1 (ko) | 2016-05-20 | 2023-05-09 | 하푼 테라퓨틱스, 인크. | 단일 도메인 혈청 알부민 결합 단백질 |
| CN109689685A (zh) | 2016-07-08 | 2019-04-26 | 斯塔滕生物技术有限公司 | 抗apoc3抗体及其使用方法 |
| EP3544629A4 (en) | 2016-11-23 | 2020-06-17 | Harpoon Therapeutics, Inc. | TRISPECIFIC PROTEINS CIBLANG PSMA AND METHODS OF USE |
| KR102275008B1 (ko) | 2016-11-23 | 2021-07-13 | 하푼 테라퓨틱스, 인크. | 전립선 특이 막 항원 결합 단백질 |
| CN110139952B (zh) * | 2016-12-09 | 2022-11-25 | 深圳华大生命科学研究院 | 骆驼科抗体可变区免疫组库构建的引物组合及应用 |
| US11535668B2 (en) | 2017-02-28 | 2022-12-27 | Harpoon Therapeutics, Inc. | Inducible monovalent antigen binding protein |
| MA50958A (fr) | 2017-04-21 | 2020-10-14 | Staten Biotechnology B V | Anticorps anti-apoc3 et leurs méthodes d'utilisation |
| AU2018265856B2 (en) | 2017-05-12 | 2023-04-27 | Harpoon Therapeutics, Inc. | Mesothelin binding proteins |
| CN115028727A (zh) | 2017-05-12 | 2022-09-09 | 哈普恩治疗公司 | 靶向msln的三特异性蛋白质及使用方法 |
| BR112020007249B1 (pt) | 2017-10-13 | 2022-11-22 | Harpoon Therapeutics, Inc | Roteína de ligação a antígeno de maturação de célula b, proteína de ligação multiespecífica e uso das referidas proteínas |
| CN111630070A (zh) | 2017-10-13 | 2020-09-04 | 哈普恩治疗公司 | 三特异性蛋白质及使用方法 |
| WO2019087115A1 (en) | 2017-10-31 | 2019-05-09 | Staten Biotechnology B.V. | Anti-apoc3 antibodies and methods of use thereof |
| US10538583B2 (en) | 2017-10-31 | 2020-01-21 | Staten Biotechnology B.V. | Anti-APOC3 antibodies and compositions thereof |
| CA3114038A1 (en) | 2018-09-25 | 2020-04-02 | Harpoon Therapeutics, Inc. | Dll3 binding proteins and methods of use |
| CA3170833A1 (en) | 2020-02-21 | 2021-08-26 | Harpoon Therapeutics, Inc. | Flt3 binding proteins and methods of use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9722131D0 (en) * | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| GB2461546B (en) * | 2008-07-02 | 2010-07-07 | Argen X Bv | Antigen binding polypeptides |
| US8444976B2 (en) * | 2008-07-02 | 2013-05-21 | Argen-X B.V. | Antigen binding polypeptides |
| AU2010249470B2 (en) * | 2009-05-20 | 2015-06-25 | Novimmune S.A. | Synthetic Polypeptide Libraries And Methods For Generating Naturally Diversified Polypeptide Variants |
| GB2476681B (en) | 2010-01-04 | 2012-04-04 | Argen X Bv | Humanized camelid VH, VK and VL immunoglobulin domains |
-
2013
- 2013-09-02 IN IN138DEN2015 patent/IN2015DN00138A/en unknown
- 2013-09-02 WO PCT/EP2013/068110 patent/WO2014033304A2/en active Application Filing
- 2013-09-02 AU AU2013310839A patent/AU2013310839B2/en active Active
- 2013-09-02 JP JP2015529046A patent/JP6283030B2/ja active Active
- 2013-09-02 CA CA2879834A patent/CA2879834A1/en not_active Abandoned
- 2013-09-02 US US14/419,881 patent/US10040870B2/en active Active
- 2013-09-02 EP EP13758830.7A patent/EP2890709A2/en not_active Withdrawn
- 2013-09-02 CN CN201380044638.9A patent/CN104583236A/zh active Pending
-
2014
- 2014-12-31 IL IL236524A patent/IL236524B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP6283030B2 (ja) | 2018-02-21 |
| EP2890709A2 (en) | 2015-07-08 |
| IL236524A0 (en) | 2015-02-26 |
| AU2013310839A1 (en) | 2015-01-29 |
| CA2879834A1 (en) | 2014-03-06 |
| CN104583236A (zh) | 2015-04-29 |
| WO2014033304A3 (en) | 2014-05-01 |
| US20150166680A1 (en) | 2015-06-18 |
| IL236524B (en) | 2019-01-31 |
| WO2014033304A2 (en) | 2014-03-06 |
| JP2015526495A (ja) | 2015-09-10 |
| US10040870B2 (en) | 2018-08-07 |
| AU2013310839B2 (en) | 2017-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN00138A (no) | ||
| CY1121832T1 (el) | Μονοκλωνικα αντισωματα κατα του παραγοντα αναπτυξεως και διαφοροποιησεως 15(gdf-15) | |
| IN2014DN08163A (no) | ||
| PH12016500823A1 (en) | Production of t cell retargeting hetero-dimeric immunoglobulins | |
| PH12015502293A1 (en) | Bispecific antibodies specific for fap and dr5, antibodies specific for dr5 and methods of use | |
| TN2017000223A1 (en) | Heterodimeric antibodies that bind cd3 and tumor antigens | |
| MY178142A (en) | Anti-phf-tau antibodies and their uses | |
| SG194466A1 (en) | Non-human animals expressing antibodies having a common light chain | |
| EP3388449A3 (en) | Cysteine engineered antibodies and conjugates | |
| EA201790043A1 (ru) | Наноносители, вырабатывающие иммунную толерантность, для вырабатывания cd8+ регуляторных т-клеток | |
| NZ629296A (en) | Humanized antibodies that recognize alpha-synuclein | |
| MX2022011659A (es) | Proteinas de union a antigeno que se unen a pd-l1. | |
| WO2013041845A3 (en) | Animals, repertoires & methods for the production of human antibodies | |
| MX2015010427A (es) | Anticuerpos anti-tnf-alfa altamente galactosilados y sus usos. | |
| IN2014CN03572A (no) | ||
| EA201400875A1 (ru) | Антитела к cd47 и способы их применения | |
| MX2014000749A (es) | Anticuerpos neutralizantes del virus de la influenza a y usos de estos. | |
| EA201890942A1 (ru) | Мультивалентные вакцины с синтетическими наноносителями | |
| MX2015012540A (es) | Ratón de cadena ligera común. | |
| EA201591113A1 (ru) | Антитела против антигена 2 дендритных клеток крови и их применение | |
| UY34343A (es) | Proteinas de unión al antígeno cd27l | |
| IL241433A0 (en) | A protocol for identifying and isolating antigens specific to b cells and creating antibodies to desired antigens | |
| MX346500B (es) | Metodos y composiciones para inmunoterapia para enfermedad neural. | |
| MX2015003541A (es) | Metodos para identificar los anticuerpos con inmunogenia reducida. | |
| NZ609707A (en) | A collection and methods for its use |